WHO ICTRP trial
Long term observational study on efficiency of a TNF-alpha blocker therapy on…
DRKS00016894 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00016894 |
|---|---|
| Public title | Long term observational study on efficiency of a TNF-alpha blocker therapy on nail psoriasis in patients with moderate to severe plaque psoriasis or psoriatic arthritis |
| Scientific title | Long term observational study on efficiency of a TNF-alpha blocker therapy on nail psoriasis in patients with moderate to severe plaque psoriasis or psoriatic arthritis - NAPSI |
| Primary sponsor | Abbott GmbH & Co. KG |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | L40 L40.5;Psoriasis;Arthropathic psoriasis;L40.5 |
| Interventions | Group 1: Patients with Psoriasis were observed during the Biologic Therapy Patients were observed during 24 months. After the initiation visit, patient data was gathered at 3,6,9,12,18 and 24 months |
| Registration date | Apr 6, 2019 |
| Target size | 450 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: